1. Multipathway In Vitro Pharmacological Characterization of Specialized Proresolving G Protein-Coupled Receptors
- Author
-
Jon Merlin, Julia Park, Teresa H. Vandekolk, Stewart A. Fabb, Jeanne Allinne, Roger J. Summers, Christopher J. Langmead, and Darren M. Riddy
- Subjects
Arthritis, Rheumatoid ,Pharmacology ,HEK293 Cells ,Scleroderma, Systemic ,Humans ,Molecular Medicine ,Receptors, Lipoxin ,Ligands ,Receptors, Formyl Peptide ,Autoimmune Diseases - Abstract
Specialized proresolving mediators (SPMs) and their cognate G protein-coupled receptors are implicated in autoimmune disorders, including chronic inflammation, rheumatoid arthritis, systemic scleroderma, and lupus erythematosus. To date, six G protein-coupled receptors (GPCRs) have been paired with numerous endogenous and synthetic ligands. However, the function and downstream signaling of these receptors remains unclear. To address this knowledge gap, we systematically expressed each receptor in a human embryonic kindney 293 (HEK293)-Flp-In-CD8a-FLAG cell system. Each receptor was pharmacologically characterized with both synthetic and putative endogenous ligands across different signaling assays, covering both G protein-dependent (G
- Published
- 2022